Pfizer Estrostep
Norethindrone acetate/ethinyl estradiol tablets approved July 2 for treatment of moderate acne vulgaris in women at least 15 years of age. The supplemental application for the oral contraceptive was submitted April 2000
Norethindrone acetate/ethinyl estradiol tablets approved July 2 for treatment of moderate acne vulgaris in women at least 15 years of age. The supplemental application for the oral contraceptive was submitted April 2000